Evidence map›Paper›PMID 36160366›Full record

ArticleArtificial intelligence review2023

Unsupervised feature selection based on incremental forward iterative Laplacian score.

Jiefang Jiang, Xianyong Zhang, Jilin Yang

Abstract read
In one paragraph

Article in Artificial intelligence review, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jiefang JiangSchool of Mathematical Sciences, Sichuan Normal University, Chengdu, 610066 China.ORCID 0000-0001-8134-4478
Xianyong ZhangSchool of Mathematical Sciences, Sichuan Normal University, Chengdu, 610066 China.ORCID 0000-0002-5135-5958
Jilin YangInstitute of Intelligent Information and Quantum Information, Sichuan Normal University, Chengdu, 610066 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Feature selection facilitates intelligent information processing, and the unsupervised learning of feature selection has become important. In terms of unsupervised feature selection, the Laplacian score (LS) provides a powerful measurement and optimization method, and good performance has been achieved using the recent forward iterative Laplacian score (FILS) algorithm. However, there is still room for advancement. The aim of this paper is to improve the FILS algorithm, and thus, feature significance (SIG) is mainly introduced to develop a high-quality selection method, i.e., the incremental forward iterative Laplacian score (IFILS) algorithm. Based on the modified LS, the metric difference in the incremental feature process motivates SIG. Therefore, SIG offers a dynamic characterization by considering initial and terminal states, and it promotes the current FILS measurement on only the terminal state. Then, both the modified LS and integrated SIG acquire granulation nonmonotonicity and uncertainty, especially on incremental feature chains, and the corresponding verification is achieved by completing examples and experiments. Furthermore, a SIG-based incremental criterion of minimum selection is designed to choose optimization features, and thus, the IFILS algorithm is naturally formulated to implement unsupervised feature selection. Finally, an in-depth comparison of the IFILS algorithm with the FILS algorithm is achieved using data experiments on multiple datasets, including a nominal dataset of COVID-19 surveillance. As validated by the experimental results, the IFILS algorithm outperforms the FILS algorithm and achieves better classification performance.

Indexed as

Feature selectionFeature significanceForward iterative Laplacian scoreGranulation nonmonotonicity and uncertaintyIncremental forward iterative Laplacian scoreUnsupervised learning

Identifiers

PMID36160366
PMCPMC9484723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.